Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Revenue (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 2 years of Revenue data on record, last reported at $237441.0 in Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $237441.0; the TTM value through Sep 2025 reached $500996.0, changed N/A, while the annual FY2021 figure was $75000.0, N/A changed from the prior year.
  • Revenue reached $237441.0 in Q3 2025 per COEP's latest filing, up from $200681.0 in the prior quarter.
  • Across five years, Revenue topped out at $4.3 million in Q3 2021 and bottomed at -$16.6 million in Q4 2021.